Please use this identifier to cite or link to this item: http://148.72.244.84:8080/xmlui/handle/xmlui/4447
Title: The Outcome of Withholding Pharmacologic Treatment in Children with Acute ITP
Authors: Jalil I Alezzi
Maghrib S. AlKhateeb
Emad Wisam Hassan
Keywords: ITP
Withholding
Outcome
Issue Date: Oct-2019
Publisher: University of Diyala - College of Medicine
Abstract: Background: ITP is a nonthreatening disorder disturbing children at any age but mostly below 5 years. Objective: To evaluate the outcome of children with acute ITP who were not specified with any pharmacologic action and linked with those who were treated. Patients and Methods: A prospective case- control study was done between Jan.2002 to May 2016 at Mukalla children and Maternity Hospital and University Hospital for Children and Mother Health in Mukalla/ Hadhramout /Yemen, where 20 children with acute ITP. the control group was 18 children given the conventional therapy. The identification and grouping of ITP were made according to the 2009 International Working Group criteria. Results: In group A there were 11( 55%) boys and 9(45%) girls, while control group B there were 18 children 10 (55.5%) boys and 8 (44.5%) girls. the ages were from 2 to 12 years. The mean age is 4.7 years with the median age at identification was 4r years. There was no statistical significant difference between both groups regarding outcome. Conclusion: The recovery percentage has some relation with age at appearance and preliminary platelet count where younger children and those with platelet amount of <20000 /µL have better recovery percentage. There was no statistical significant difference between both groups regarding outcome
URI: https://djm.uodiyala.edu.iq/index.php/djm
http://148.72.244.84:8080/xmlui/handle/xmlui/4447
ISSN: Print ISSN 2219-9764
Online ISSN 2617-8982
Appears in Collections:مجلة ديالى الطبية / Diyala Journal of Medicine

Files in This Item:
File Description SizeFormat 
11-Jalil I Alezzi.pdf334.79 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.